{
    "name": "hydrocortisone topical",
    "comment": "Rx, OTC",
    "other_names": [
        "Westcort",
        "Locoid",
        "Aquanil",
        "Calmurid Cream",
        "Cetacort",
        "Claritin Skin Itch Relief",
        "Coraz",
        "CortaGel",
        "Cortaid",
        "Cortate",
        "Cortisone-10 Poison Ivy Relief Pads",
        "Cortisone-10 Quick Shot",
        "Cortizone",
        "Cortoderm",
        "Dermacort",
        "Dermazene Cream",
        "DermiCort",
        "Emo Cort",
        "Hyderm",
        "Hydrocort",
        "HydroSKIN",
        "HydroVal",
        "Hytone",
        "LactiCare",
        "AlaCort",
        "Locoid Lipocream",
        "Massengill",
        "Neosporin Eczema Essentials Anti-Itch Cream",
        "Nutracort",
        "Pediaderm HC",
        "Penecort",
        "Preparation H Anti-Itch Cream",
        "Prevex HC",
        "Proctocort",
        "Proctocream",
        "Sarna HC",
        "Sarnol",
        "Texacort",
        "Timodine",
        "Uniroid HC",
        "AlaScalpt"
    ],
    "classes": [
        "Corticosteroids",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/westcort-locoid-hydrocortisone-topical-343522",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids; corticosteroids generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels; topical corticosteroids should be used during pregnancy only if potential benefits justify potential risk to fetus; should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Not know whether topical administration could result in sufficient systemic absorption to produce detectable quantities in breast milk; systemically administered corticosteroids are secreted into breast milk in quantities not likely to have deleterious effect on infant; nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Underlying infection",
                "Hypersensitivity",
                "Ophthalmic use",
                "Treatment of diaper dermatitis"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Chronic topical corticosteroid therapy may interfere with growth and development in children",
                "Use lower potency in children; may absorb proportionally larger amounts after topical application and may cause systemic effects",
                "Occlusive dressings, prolonged use, application to large surface areas, or application to denuded skin, may increase percutaneous absorption, which may result in Cushing syndrome, glycosuria, and hyperglycemia",
                "Prolonged use may increase risk of Kaposi's sarcoma",
                "Prolonged use may increase risk of secondary infection, may mask acute infection, limit response to vaccines, and prolong or exacerbate viral infections; avoid exposure to measles or chickenpox while receiving therapy; not for the treatment of ocular herpes simplex, cerebral malaria, fungal infections, or viral hepatitis; observe patients with latent tuberculosis closely; restrict use in active tuberculosis",
                "Acute myopathy reported with high dose corticosteroids, especially patients with neuromuscular transmission disorders",
                "Psychiatric disturbances including euphoria, insomnia, mood swings, and personality changes reported with corticosteroid use",
                "Allergic contact dermatitis may occur; diagnosed as failure to heal rather than exacerbation; discontinue therapy and treat appropriately if it occurs",
                "May suppress hypothalamic-pituitary-adrenal axis, especially in patients receiving high doses for prolonged periods of time and younger children, which may result in adrenal crisis",
                "Anaphylactoid reactions reported in patients receiving corticosteroids",
                "Local desensitization (irritation, redness) reported; discontinue if it occurs",
                "Use caution in patients with diabetes, cardiovascular disease, hepatic impairment, myocardial infarction, myasthenia gravis, osteoporosis, ocular disease, renal impairment, or thyroid disease"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Skin atrophy",
            "percent": "2"
        },
        {
            "name": "Striae",
            "percent": null
        },
        {
            "name": "Acneform lesions",
            "percent": null
        },
        {
            "name": "Perioral dermatitis",
            "percent": null
        },
        {
            "name": "Folliculitis",
            "percent": null
        },
        {
            "name": "Itching",
            "percent": null
        },
        {
            "name": "Pigmentation changes",
            "percent": null
        },
        {
            "name": "HPA suppression",
            "percent": null
        },
        {
            "name": "with higher potency used",
            "percent": null
        },
        {
            "name": "wk",
            "percent": null
        }
    ]
}